ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Current drug treatment of mental disorders
Psychiatric disorders significantly impact global health, with treatment-resistant patients facing serious complications. Schizophrenia shows treatment resistance in approximately one-third of cases, while antidepressants are effective in half of users. The rising incidence of suicidal ideation in b
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia#858032
- Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia#1073217
- Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.#185768
- Safety and Efficacy of MP-214 in Patients With Schizophrenia#871436
- Controlled Substances in the New Administration: Cannabis, Psychedelics, and Opioids#168661
Record · ID 1160467
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive